David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center
Advertisement
Articles by David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center
Advertisement
Latest Updated Articles
Global Use of Frontline Therapy in Metastatic Gastric CancerPublished: June 2nd 2020 | Updated:
Perioperative Strategies in Metastatic Gastric CancerPublished: June 2nd 2020 | Updated:
Is Frontline IO Therapy Appropriate in Gastric Cancer?Published: June 2nd 2020 | Updated:
Metastatic Gastric Cancer: Identifying Disease ProgressionPublished: June 2nd 2020 | Updated:
Emerging Biomarkers in Metastatic Gastric CancerPublished: June 2nd 2020 | Updated:
Switch Maintenance in Gastric Cancer: Results of JAVELIN Gastric 100Published: June 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
4
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
5